Company
Funding data: Recent Funding. Each amount links to the announcement it came from.
Funding data: Recent Funding. Each amount links to the announcement it came from.
| Date | Stage | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2026 | Series B+ | $237M | — | Bristol Myers Squibb, Tempus, AstraZeneca, NEA | Pulse 2.0 ↗ |
Bristol Myers Squibb · Tempus · AstraZeneca · NEA